Moderna’s newly approved vaccine could allow manufacturers to respond more rapidly to changing influenza strains.
The Food and Drug Administration just approved the new type of flu vaccine for adults ages 50 and older. It relies on the ...
A research team led by Director Kim V. Narry at the Center for RNA Research within the Institute for Basic Science (IBS) has discovered compact viral RNA elements that can make mRNA more stable and ...
For older adults, the flu vaccine could look a little different this year.
Verywell Health on MSN
Does the new mRNA flu shot work better than a traditional flu shot? What the science says
Fact checked by Elizabeth GallKey takeawaysThe FDA approved mFLUSIVA, the first mRNA flu vaccine, for adults 50 and older.Clinical trials showed that mFLUSIVA was approximately 27% more effective than ...
Vaccines have been reliably and affordably protecting people from diseases worldwide for centuries. Until the COVID-19 ...
The new mRNA vaccine provides more protection than the standard flu shot.
Flusiva is the first FDA-approved seasonal influenza vaccine to use mRNA technology. Beyond influenza itself, how significant is this approval for the future development of vaccines and infectious ...
An mRNA-based flu (influenza) vaccine for adults 50 and over, Moderna’s mFLUSIVA, was approved by the U.S. Food and Drug Administration (FDA) on August 5. The approval offers older adults, who are at ...
Share on Pinterest The FDA approved a new mRNA flu vaccine for older adults ahead of the upcoming 2026–2027 flu season. fotostorm/E+/Getty Images The Food and Drug Administration (FDA) has approved a ...
From mRNA to RFK Jr. to measles, who (or what) are we to trust?
Some results have been hidden because they may be inaccessible to you
Show inaccessible results